Portal vein thrombosis in patients with cirrhosis: underdiagnosis and undertreatment?

Intern Emerg Med. 2016 Dec;11(8):1037-1040. doi: 10.1007/s11739-016-1463-1. Epub 2016 May 23.

Authors

Aaron Liew^{1

2

3}, James Douketis⁴

Affiliations

¹ Portiuncula University Hospital & Galway University Hospital, Saolta University Health Care Group, Galway, Ireland.
² National University of Ireland Galway (NUIG), Galway, Ireland.
³ Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.
⁴ St. Joseph's Healthcare, Department of Medicine, McMaster University, F-544, 50 Charlton Ave East, Hamilton, ON, L8N 4A6, Canada. jdouket@mcmaster.ca.

PMID: 27216797
DOI: 10.1007/s11739-016-1463-1

No abstract available

MeSH terms

Administration, Oral
Anticoagulants / pharmacology
Anticoagulants / therapeutic use*
Heparin, Low-Molecular-Weight / pharmacology
Heparin, Low-Molecular-Weight / therapeutic use
Humans
Liver Cirrhosis / complications*
Portal Vein / physiopathology*
Venous Thrombosis / mortality
Venous Thrombosis / therapy*
Vitamin K / agonists

Substances

Anticoagulants
Heparin, Low-Molecular-Weight
Vitamin K